ENO1 Promotes OSCC Migration and Invasion by Orchestrating IL-6 Secretion from Macrophages via a Positive Feedback Loop

Oral squamous cell carcinoma (OSCC) has a five-year survival rate of less than 50% due to its susceptibility to invasion and metastasis. Crosstalk between tumor cells and macrophages has been proven to play a critical role in tumor cell migration and invasion. However, the specific mechanisms by which tumor cells interact with macrophages have not been fully elucidated. This study sought to investigate the regulatory mechanism of tumor cell-derived alpha-enolase (ENO1) in the interaction between tumor cells and macrophages during OSCC progression. Small interfering RNA (siRNA) transfection and recombinant human ENO1 (rhENO1) stimulation were used to interfere with the interaction between tumor cells and macrophages. Our results showed that ENO1 was expressed higher in CAL27 cells than in HaCaT cells and regulated lactic acid release in CAL27 cells. Conditioned medium of macrophages (Macro-CM) significantly up-regulated the ENO1 mRNA expression and protein secretion in CAL27 cells. ENO1 promoted the migration and invasion of tumor cells by facilitating the epithelial–mesenchymal transition (EMT) through macrophages. ENO1 orchestrated the IL-6 secretion of macrophages via tumor cell-derived lactic acid and the paracrine ENO1/Toll-like receptor (TLR4) signaling pathway. In turn, IL-6 promoted the migration and invasion of tumor cells. Collectively, ENO1 promotes tumor cell migration and invasion by orchestrating IL-6 secretion of macrophages via a dual mechanism, thus forming a positive feedback loop to promote OSCC progression. ENO1 might be a promising therapeutic target which is expected to control OSCC progression.

[1]  Ying Lin,et al.  Curcumin Reprograms TAMs from a Protumor Phenotype towards an Antitumor Phenotype via Inhibiting MAO-A/STAT6 Pathway , 2022, Cells.

[2]  T. Beißbarth,et al.  Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain , 2022, Oncogene.

[3]  M. Jiang,et al.  STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma , 2022, Cells.

[4]  Yilin Yan,et al.  Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer , 2022, Journal of translational medicine.

[5]  S. Hasnain,et al.  MUC1 mediated macrophage activation promotes colitis-associated colorectal cancer via activating the IL-6/STAT3 axis. , 2022, Cellular and molecular gastroenterology and hepatology.

[6]  A. Mahajan,et al.  Salivary and tumour tissue miR-21 for prediction of cervical lymph node metastasis in patients with oral squamous cell carcinoma: an observational study. , 2022, The Lancet. Oncology.

[7]  Yongmei Yin,et al.  TRPC5OS induces tumorigenesis by increasing ENO1-mediated glucose uptake in breast cancer , 2022, Translational oncology.

[8]  Ming Yan,et al.  CD73 in small extracellular vesicles derived from HNSCC defines tumour‐associated immunosuppression mediated by macrophages in the microenvironment , 2022, Journal of extracellular vesicles.

[9]  Zhiwei Wang,et al.  Lactate promotes the growth of patient-derived organoids from hepatopancreatobiliary cancers via ENO1/HIF1α pathway and does not affect their drug sensitivities , 2022, Cell death discovery.

[10]  S. Patnaik,et al.  Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway , 2022, Cancer cell international.

[11]  Xuesu Xiao,et al.  Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer , 2022, Cell Death & Disease.

[12]  M. Xiao,et al.  M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop , 2022, Journal of Experimental & Clinical Cancer Research.

[13]  G. Christofori,et al.  Distinct contributions of partial and full EMT to breast cancer malignancy. , 2021, Developmental cell.

[14]  Xiukun Lin,et al.  Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment , 2021, International journal of biological sciences.

[15]  A. Elmusrati,et al.  Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma , 2021, International Journal of Oral Science.

[16]  Hsuan-Yu Chen,et al.  ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling–Driven Epithelial-to-Mesenchymal Transition , 2021, Cancer Research.

[17]  Chunyi Zhang,et al.  ENO1 promotes antitumor immunity by destabilizing PD-L1 in NSCLC , 2021, Cellular & Molecular Immunology.

[18]  M. Sakaguchi,et al.  PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β1 , 2021, International journal of oncology.

[19]  Qingwei Zhu,et al.  Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17 , 2021, Theranostics.

[20]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[21]  S. Raghav,et al.  CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis , 2021, JCI insight.

[22]  Xi Yang,et al.  Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC , 2020, Cell Death & Disease.

[23]  C. R. Leemans,et al.  Head and neck squamous cell carcinoma , 2020, Nature Reviews Disease Primers.

[24]  Lianyu Chen,et al.  A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and Cancer Cells Regulates Pancreatic Cancer Metastasis , 2020, Cancer Research.

[25]  Keqiu Jiang,et al.  Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis , 2020, Cell Death & Disease.

[26]  J. Yates,et al.  Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration. , 2020, Oral oncology.

[27]  David L. Williams,et al.  Lactate Suppresses Macrophage Pro-Inflammatory Response to LPS Stimulation by Inhibition of YAP and NF-κB Activation via GPR81-Mediated Signaling , 2020, Frontiers in Immunology.

[28]  N. Prakash,et al.  Evaluation of density of tumor-associated macrophages using CD163 in histological grades of oral squamous cell carcinoma, an immunohistochemical study , 2020, Journal of oral and maxillofacial pathology : JOMFP.

[29]  Ping-Chih Ho,et al.  Lactate modulation of immune responses in inflammatory versus tumour microenvironments , 2020, Nature Reviews Immunology.

[30]  A. Rustgi,et al.  EMT, MET, Plasticity, and Tumor Metastasis. , 2020, Trends in cell biology.

[31]  H. Saiyin,et al.  The circ-AMOTL1/ENO1 Axis Implicated in the Tumorigenesis of OLP-Associated Oral Squamous Cell Carcinoma , 2020, Cancer management and research.

[32]  Sushil Kumar,et al.  Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression , 2020, Science.

[33]  Long Yu,et al.  Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis , 2020, Cell Death & Disease.

[34]  Dawang Zhou,et al.  Ectosomal PKM2 Promotes HCC by Inducing Macrophage Differentiation and Remodeling the Tumor Microenvironment. , 2020, Molecular cell.

[35]  Lan Zhang,et al.  Lactic acid promotes macrophage polarization through MCT-HIF1α signaling in gastric cancer. , 2020, Experimental cell research.

[36]  M. Campone,et al.  Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor Phenotype , 2020, Cancer Immunology Research.

[37]  Z. Zou,et al.  Preventing Candida albicans from subverting host plasminogen for invasive infection treatment , 2020, Emerging microbes & infections.

[38]  C. O’Farrelly,et al.  The Immune Consequences of Lactate in the Tumor Microenvironment. , 2020, Advances in experimental medicine and biology.

[39]  B. Ren,et al.  Metabolic regulation of gene expression by histone lactylation , 2019, Nature.

[40]  U. Rodeck,et al.  Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis , 2019, Front. Oncol..

[41]  L. Galluzzi,et al.  Macrophages and Metabolism in the Tumor Microenvironment. , 2019, Cell metabolism.

[42]  H. Hsu,et al.  MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer , 2019, Molecular Cancer.

[43]  C. Mărgăritescu,et al.  Epidemiological and Histopathological Aspects of Tongue Squamous Cell Carcinomas-Retrospective Study , 2018, Current health sciences journal.

[44]  Yue Xu,et al.  Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer , 2018, Cell cycle.

[45]  M. Götte,et al.  Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways , 2017, Molecular Cancer.

[46]  Yong-jie Zhou,et al.  Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice , 2016, Journal of Experimental & Clinical Cancer Research.

[47]  C. Derambure,et al.  Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function , 2016, Scientific Reports.

[48]  T. Welling,et al.  Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. , 2014, Gastroenterology.

[49]  G. Cline,et al.  Functional polarization of tumour-associated macrophages by tumour-derived lactic acid , 2014, Nature.

[50]  G. Wang,et al.  Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma , 2014, Molecular Cancer.

[51]  Chi V. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[52]  T. Wong,et al.  ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. , 2010, European journal of cancer.